Dräger has received the Zenith Award from the American Association for Respiratory Care for delivering outstanding products and services to the respiratory care profession. The award was presented during the AARC 60th International Respiratory Convention.
Established in 1989, the AARC Zenith Award is considered the “people’s choice” award of the respiratory care profession and highly prized by its recipients. Each year, AARC asks its membership, which comprises 52,000 respiratory therapists and other clinicians, to vote for those manufacturers, service organizations and supply companies that provide the respiratory care community with exemplary service based on the following criteria:
• quality of equipment and/or supplies;
• accessibility and helpfulness of sales personnel;
• responsiveness;
• service record;
• truth in advertising; and
• support of the respiratory care profession.
For the sixth straight year, AARC members selected Dräger for this prestigious recognition. Dräger’s Respiratory Care devices span the spectrum of critical care, neonatal care, acute care, noninvasive therapy and emergency/transport ventilation.
“Our members have consistently chosen Dräger as a company that provides products and services to help them improve patient care,” said AARC Executive Director and CEO Thomas Kallstrom, MBA, RRT, FAARC. “We are pleased to again this year honor Dräger for its commitment to respiratory care in terms of product excellence, exceptional customer service and overall support of our profession.“
“In this era of health care reform, health systems and hospitals are tasked with delivering high-quality care at an affordable cost and those in the respiratory care profession play a central role in this effort,” said Ed Coombs, MA RRT-NPS/ACCS, FAARC Director of Marketing-Intensive Care & Neonatal Care Draeger Medical Inc. “From managing patient respiratory status in the acute care setting to facilitating effective long-term care, the work of respiratory care professionals is critical to saving lives, improving outcomes, reducing readmissions and enhancing quality of life. We are honored that the members of the AARC have recognized Dräger as their partner in these efforts.”
